Abstract: A method for preparing a transdermal absorption composition includes mixing rotigotine and an antioxidant at a weight ratio of 1:0.0001 to 0.1. A transdermal therapeutic system includes a substrate and a drug-containing adhesive layer disposed on the substrate and including an antioxidant at a weight ratio of 1:0.0001 to 0.1. The method and system of the present invention suppress the crystallization of rotigotine as well as the generation of related substances, thereby increasing the long-term storage stability of a therapeutic product containing rotigotine or related substances.

Abstract: Disclosed herein is a composite piston pin including a pipe-shaped outer layer made of reinforced fibers; an inner layer coupled to the outer layer along an inner surface of the outer layer, and made of reinforced fibers having lower elasticity than the outer layer; and a resin material including an epoxy resin composition and cyanate ester, and impregnated into the reinforced fibers of the outer layer and the inner layer.

Abstract: The present invention relates to a method for preparing a bio-based polycarbonate ester, the method comprising the steps of: (1) preparing a compound represented by chemical formula 3 by converting a compound represented by chemical formula 2 into an intermediate reactant having an easily detachable functional group, followed by a nucleophilic reaction with phenol; and (2) preparing a compound including a repeat unit represented by chemical formula 1 by a polycarbonate melt condensation polymerization of the compound represented by chemical formula 3, prepared in step (1), a compound represented by chemical formula 4, and 1,4:3,6-dianhydrohexitol. The bio-based polycarbonate ester according to the present invention can regulate merits and demerits of physical properties obtained from each repeat unit, and can be favorably used for various uses due to high degrees of transparency and heat resistance thereof.

Abstract: The present invention relates to a composition and health functional food for inhibiting apoptosis of cranial nerve cells, and to a method for inhibiting apoptosis, wherein the composition and health functional food comprising a phosphodiesterase type 5 active inhibitor. According to the present invention, the PDE5 inhibitor exhibits a protective effect on nerve cells by inhibiting apoptosis of cranial nerve cells. Thus, the present invention can be effectively used to prevent, alleviate, and treat cranial nerve disease.

Abstract: A polymer resin composition capable of providing a synthetic resin showing physical properties of improved heat resistance or impact resistance is provided, in which the polymer resin composition includes a polyester tetrapolymer containing a residue of a dicarboxylic acid component containing terephthalic acid and a residue of a diol component containing dianhydrohexitol, and one or more terpolymers selected from the group consisting of an unsaturated nitrile-diene-based rubber-aromatic vinyl graft terpolymer, an alkyl methacrylate-diene-based rubber-aromatic vinyl graft terpolymer, and an alkyl methacrylate-silicone/alkyl acrylate graft terpolymer.

Abstract: The present invention relates to a composition and health functional food for inhibiting apoptosis of cranial nerve cells, and to a method for inhibiting apoptosis, wherein the composition and health functional food comprising a phosphodiesterase type 5 active inhibitor. According to the present invention, the PDE5 inhibitor exhibits a protective effect on nerve cells by inhibiting apoptosis of cranial nerve cells. Thus, the present invention can be effectively used to prevent, alleviate, and treat cranial nerve disease.

Abstract: Provided is an immunogenic composition comprising 15 different polysaccharide-protein conjugates. Each of the conjugates comprises a capsular polysaccharide prepared from different serotype Streptococcus pneumoniae conjugated to a carrier protein, that is, serotypes 1, 2, 3, 4, 5, 6A, 6B, 7F, 9N, 9V, 14, 18C, 19A, 19F and 23F. An immunogenic composition formulated into a vaccine comprising an aluminum-based adjuvant increases application range with respect to pneumococcal diseases in infants and children.

Abstract: Provided are components for vehicles, electric/electronic products, home appliances, office equipments or household items, which are manufactured using a high heat resistant polymer resin composition capable of providing an environmentally friendly biomass-containing synthetic resin which exhibits improved chemical resistance.

Abstract: The present invention relates to a polycyclohexylenedimethylene terephthalate resin composition having improved reflectivity, heat resistance, and yellowing resistance. The resin composition according to one embodiment of the present invention includes 40 to 95 wt % of polycyclohexylenedimethylene terephthalate resin; 1 to 50 wt % of a white pigment; and 1 to 50 wt % of a filler, and the amount of germanium (Ge) atoms remaining in the resin is 30 to 1,000 ppm based on the weight of the resin.

Abstract: A polyester resin copolymerized with isosorbide and 1,4-cyclohexane dimethanol and having an improved impact strength, and a method for preparing the same are disclosed. The copolymerized polyester resin has an alternating structure of acid moieties which are derived from acid components and diol moieties which are derived from diol components, wherein the acid components comprise terephthalic acid, and the diol components comprise (i) 5˜99 mol % of 1,4-cyclohexanedimethanol and (ii) 1˜60 mol % of isosorbide with respect to the total diol components.

Abstract: The present invention relates to a method for separating volatile substances, particularly iodine, diiodised aromatic compounds and/or mixtures thereof, from material mixtures containing said compounds. The invention further relates to a device for producing polyarylene sulphides, by means of which volatile substances, particularly iodine and diiodised aromatic compounds, can be separated from the polymers.

Abstract: A thermoplastic molded product including a decorative material having superior heat resistance, impact strength and flexural strength is disclosed. The thermoplastic molded product is useful for a window glass substitute, a partition, a decorative panel, a decorative film, and so on. The thermoplastic molded product comprises a copolymerized polyester resin sheet made of a copolymerized polyester resin; and at least one decorative material laminated on the copolymerized polyester resin sheet, the lamination being performed by applying heat and pressure to the copolymerized polyester resin sheet and the decorative material. The copolymerized polyester resin has an alternating structure of acid moieties which are derived from acid components and diol moieties which are derived from diol components, and the acid components comprise terephthalic acid, and the diol components comprise (i) 5˜99 mol % of 1,4-cyclohexanedimethanol and (ii) 1˜60 mol % of isosorbide with respect to the total diol components.

Abstract: The present invention relates to a polyarylene sulfide resin composition having excellent impact resistance in which a polyarylene sulfide resin having a specific end group, an epoxy-containing olefin-based elastomer, and/or an organic or inorganic filler are included, and a preparation method thereof.

Abstract: A fusion protein comprising factor VII (FVII) and transferrin according to the present invention has an improved specific activity of FVII compared to existing FVII fusion proteins comprising other fusion partners than transferrin, and thus can be effectively used in a therapy using FVII.

Abstract: The present invention relates to: a compound selected from the group consisting of a tricyclic compound having the structure of formula I, a pharmaceutically acceptable salt, an isomer, a solvate and a precursor thereof; and a use thereof. The compound effectively controls GPR40, and thus, can be effectively used for the prophylaxis or treatment of diseases associated with GPR40, for example, diabetes and many other diseases.

Abstract: The present invention provides an improved method of producing a capsular polysaccharide having a pneumococcal serotype. The method according to the present invention includes a step of additionally culturing bacterial cells producing a pneumococcal serotype without pH adjustment, thereby removing a protein precipitation process by acidification with a pH adjuster.

Abstract: Provided is a transdermal delivery system (for example, in the form of a patch) having a double-layer structure including a drug-containing matrix layer and an adhesive layer, wherein the drug-containing matrix layer is obtained by completely dissolving donepezil using a certain polymer and then formulating along with an adhesive; and a process for preparing the same. The transdermal delivery system according to the present invention does not show any crystallization of donepezil in the formulation, can release donepezil at a uniform rate for a long time, and can inhibit the release dumping phenomenon that occurs in a transdermal delivery system having a single-layer structure.

Abstract: Disclosed is a fusion protein comprising blood coagulation factor IX (FIX) and transferrin. The fusion protein exhibits improved specific FIX activity, as compared to native FIX, and can be useful in the treatment of FIX deficiency-associated diseases.

Abstract: The present invention relates to a rivastigmine-containing patch having improved storage stability and proper release property.

Abstract: A chemical resistant polymer composition for a center fascia includes a resin composition consisting of 10 to 20% by weight of a polyester copolymer containing a residue of a dicarboxylic acid component containing terephthalic acid and a residue of a diol component containing dianhydrohexitoll; 15 to 25% by weight of polytrimethyleneterephthalate; 10 to 20% by weight of one or more copolymers selected from the group consisting of an unsaturated nitrile-diene-based rubber-aromatic vinyl graft copolymer, an alkylmethacrylate-diene-based rubber-aromatic vinyl graft copolymer, and an alkylmethacrylate-silicone/alkylacrylate graft copolymer; and 50 to 65% by weight of polycarbonate based on the weight of the resin composition. The polymer composition further comprises 0.1 to 10 parts by weight of a phosphite-based antioxidant, based on 100 parts by weight of the resin composition.